[Chaperon-induction therapy for peptic ulcers].
Otaka
Michiro
M
First Department of Internal Medicine, Akita University School of Medicine.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D002336:Carnosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005753:Gastric Mucosa / Q000378:metabolism; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins / Q000096:biosynthesis* / Q000502:physiology; D006801:Humans; D018832:Molecular Chaperones; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000494:pharmacology; D010437:Peptic Ulcer / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D013268:Stimulation, Chemical; D013312:Stress, Physiological / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology; D017967:Zinc Compounds
D000894:Anti-Inflammatory Agents, Non-Steroidal; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D018832:Molecular Chaperones; D009942:Organometallic Compounds; D017967:Zinc Compounds; C061957:polaprezinc; D013973:Thyrotropin-Releasing Hormone; D002336:Carnosine; D001241:Aspirin